PPA
KYNB

Parametric Portfolio Associates’s Kyntra Bio KYNB Stock Holding History

Parametric Portfolio Associates’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$923K Sell
3,070
-853
-22% -$297K ﹤0.01% 2818
2021
Q4 		$1.38M Buy
3,923
+1,430
+57% +$445K ﹤0.01% 2646
2021
Q3 		$637K Sell
2,493
-776
-24% -$275K ﹤0.01% 2997
2021
Q2 		$2.18M Buy
3,269
+1,079
+49% +$622K ﹤0.01% 2386
2021
Q1 		$1.9M Sell
2,190
-165
-7% -$176K ﹤0.01% 2811
2020
Q4 		$2.18M Sell
2,355
-267
-10% -$281K ﹤0.01% 2599
2020
Q3 		$2.69M Buy
2,622
+441
+20% +$475K ﹤0.01% 2314
2020
Q2 		$2.21M Buy
2,181
+3
+0.1% +$2.79K ﹤0.01% 2440
2020
Q1 		$1.89M Sell
2,178
-64
-3% -$63.6K ﹤0.01% 2413
2019
Q4 		$2.4M Sell
2,242
-750
-25% -$766K ﹤0.01% 2576
2019
Q3 		$2.77M Buy
2,992
+876
+41% +$962K ﹤0.01% 2443
2019
Q2 		$2.39M Sell
2,116
-494
-19% -$541K ﹤0.01% 2545
2019
Q1 		$3.55M Buy
2,610
+474
+22% +$643K ﹤0.01% 2251
2018
Q4 		$2.47M Buy
2,136
+735
+52% +$826K ﹤0.01% 2441
2018
Q3 		$2.13M Buy
1,401
+95
+7% +$146K ﹤0.01% 2672
2018
Q2 		$2.04M Buy
1,306
+223
+21% +$291K ﹤0.01% 2682
2018
Q1 		$1.25M Buy
1,083
+105
+11% +$138K ﹤0.01% 2903
2017
Q4 		$1.16M Sell
978
-798
-45% -$1M ﹤0.01% 2940
2017
Q3 		$2.39M Buy
1,776
+1,193
+205% +$1.26M ﹤0.01% 2472
2017
Q2 		$471K Buy
583
+178
+44% +$124K ﹤0.01% 3398
2017
Q1 		$249K Buy
+405
New +$247K ﹤0.01% 3507
2016
Q2 		– Sell
-1,368
Closed -$728K – 3865
2016
Q1 		$728K Buy
+1,368
New +$682K ﹤0.01% 3124

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Parametric Portfolio Associates's KYNB Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Kyntra Bio (KYNB) stake by 22% in Q1 2022, selling an estimated $297K and leaving 3,070 shares worth $923K. The position accounts for ﹤0.01% of the portfolio, ranked #2818.

Parametric Portfolio Associates first reported a position in KYNB in Q1 2016 and has held it in 22 quarters since. The position peaked at $3.55M in Q1 2019. 156 funds tracked by Wall St. Rank hold KYNB as of Q1 2022.

  • Parametric Portfolio Associates held 3,070 shares of Kyntra Bio worth $923K as of Q1 2022.
  • Parametric Portfolio Associates sold 853 Kyntra Bio shares in Q1 2022, an estimated $297K.
  • Kyntra Bio made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2818 holding.
  • Parametric Portfolio Associates first reported a position in Kyntra Bio in Q1 2016 and has held it in 22 quarters since.
  • Parametric Portfolio Associates's Kyntra Bio position peaked at $3.55M in Q1 2019.
  • 156 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.